Lely Solari

Lely Solari

Auto-generated profile, based on publicly available information

Lely Solari

Centro Nacional de Salud Publica, Instituto Nacional de Salud, Lima, Peru

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in International Journal of Infectious Diseases
Verified
Journal Article
Closed access
LSLely Solari
Lely Solari
ASAlonso Soto
Alonso Soto
JAJuan Carlos Agapito
Juan Carlos Agapito
VAVilma Acurio
Vilma Acurio
DVDante Vargas
Dante Vargas
PSPatrick van der Stuyft
Patrick van der Stuyft

1 April 2008 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ASAlonso Soto
Alonso Soto
LSLely Solari
Lely Solari
JAJuan Agapito
Juan Agapito
CACarlos Acuna-Villaorduna
Carlos Acuna-Villaorduna
MLMarie-Laurence Lambert
Marie-Laurence Lambert
PSPatrick Van der Stuyft
Patrick Van der Stuyft
This study developed a clinical score based on clinical and radiographic data for the diagnosis of smear-negative pulmonary tuberculosis (SNPT). SNPT was defined as a positive culture in Ogawa in a patient with two negative sputum smears. Data from patients admitted to the emergency ward with respiratory symptoms and negative acid-fast bacilli (AFB) smears was analyzed by means of logistic regression to develop the predictive score.Two hundred and sixty two patients were included. Twenty patients had SNPT. The variables included in the final model were hemoptysis, weight loss, age > 45 years old, productive cough, upper-lobe infiltrate, and miliary infiltrate. With those, a score was constructed. The score values ranged from -2 to 6. The area under the curve for the ROC curve was 0.83 (95% CI 0.74-0.90). A score of value 0 or less was associated with a sensitivity of 93% and a score of more than 4 points was associated with a specificity of 92% for SNPT. Fifty-two point twenty-nine percent of patients had scores of less than one or more than four, what provided strong evidence against and in favor, respectively, for the diagnosis of SNPT. The score developed is a cheap and useful clinical tool for the diagnosis of SNPT and can be used to help therapeutic decisions in patients with suspicion of having SNPT

1 February 2020 in The International Journal of Tuberculosis and Lung Disease
Verified
Journal Article
Closed access
NQN. Quispe
N. Quispe
LAL. Asencios
L. Asencios
COC. Obregon
C. Obregon
GVG. E. Velásquez
G. E. Velásquez
CMC. D. Mitnick
C. D. Mitnick
LSL. Solari
L. Solari
BACKGROUND: Peru has one of the highest burdens of multidrug-resistant tuberculosis (MDR-TB), but universal drug susceptibility testing (DST) has not yet been achieved.OBJECTIVE: To estimate the proportion of drug resistance among smear-positive TB patients in Peru.DESIGN: From September 2014 to March 2015, we performed a national drug resistance survey of patients aged ≥15 years; TB was diagnosed based on sputum smear positivity. We performed DST at the National Reference Laboratory of the Peruvian National Institute of Health, Lima, Peru, using the proportion method in Middlebrook 7H10 agar for four first-line drugs and six second-line drugs, and the Wayne method for pyrazinamide.RESULTS: Of the 1908 new and 272 previously treated patients included in the analysis, 638 (29.3%) patients had resistance to at least one first-line drug. MDR-TB was diagnosed in 7.3% of new and 16.2% of previously treated patients (P < 0.001). There were five (0.2%) patients with extensively drug-resistant TB.CONCLUSION: MDR-TB has increased to 7.3% in new patients from 5.3% in the previous survey, indicating that resistance to anti-tuberculosis drugs is increasing in Peru. Ongoing community transmission of resistant strains highlights an urgent need for early diagnosis, optimised treatment and effective contact tracing of MDR-TB patients.

1 February 2005 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
CMCiro Maguiña
Ciro Maguiña
JPJorge Flores del Pozo
Jorge Flores del Pozo
ATAngélica Terashima
Angélica Terashima
EGEduardo Gotuzzo
Eduardo Gotuzzo
HGHumberto Guerra
Humberto Guerra
LSLely Solari
Lely Solari
Anthrax is a zoonosis produced by Bacillus anthracis, and as an human infection is endemic in several areas in the world, including Peru. More than 95% of the reported naturally acquired infections are cutaneous, and approximately 5% of them can progress to meningoencephalitis. In this study we review the clinical and epidemiological characteristics of the patients with diagnosis of cutaneous anthrax evaluated between 1969 and 2002 at the Hospital Nacional Cayetano Heredia (HNCH) and the Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru. Seventy one patients were included [49/71 (69%) of them men], with a mean age of 37 years. The diagnoses were classified as definitive (44%) or probable (56%). The most common occupation of the patients was agriculture (39%). The source of infection was found in 63 (88.7%) patients. All the patients had ulcerative lesions, with a central necrosis. Most of the patients (65%) had several lesions, mainly located in the upper limbs (80%). Four patients (5.6%) developed meningoencephalitis, and three of them eventually died. In conclusion, considering its clinical and epidemiological characteristics, cutaneous anthrax must be included in the differential diagnosis of skin ulcers. A patient with clinical suspicion of the disease should receive effective treatment soon, in order to avoid neurological complications which carry a high fatality rate.

1 May 2004 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MHMaria Cecilia Huaman
Maria Cecilia Huaman
NRNorma Roncal
Norma Roncal
SNShusuke Nakazawa
Shusuke Nakazawa
TLTon That Ai Long
Ton That Ai Long
LGLucia Gerena
Lucia Gerena
HKHiroji Kanbara
Hiroji Kanbara
In vitro drug sensitivity to chloroquine (CQ), mefloquine (MQ) and quinine was investigated in 60 culture-adapted Plasmodium falciparum isolates from malaria patients in Padrecocha, a village in the Amazonian Department of Loreto, Peru. All isolates showed resistance to CQ, decreased susceptibility to quinine, and sensitivity to MQ. These isolates were examined for mutations in the P. falciparum multidrug resistance 1 (pfmdr1) and chloroquine resistance transporter (pfcrt) genes previously linked to CQ resistance. The mutations N86Y and D1246Y, two of the five mutations commonly observed in the pfmdr1 gene of CQ-resistant clones, were not found. The pfcrt mutation K76T, associated with CQ resistance, was identified in all the isolates tested. Sequence analysis of codons 72–76 in the pfcrt gene showed the haplotypes SVMNT and CVMNT.

5 January 2011 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
PDF file
ASAlonso Soto
Alonso Soto
LSLely Solari
Lely Solari
EGEduardo Gotuzzo
Eduardo Gotuzzo
RARoberto Acinelli
Roberto Acinelli
DVDante Vargas
Dante Vargas
PSPatrick Van der Stuyft
Patrick Van der Stuyft